Current research indicates that low-dose aspirin may be beneficial in reducing the risk of developing and dying from several types of cancer. Jill Kolesar, a clinical pharmacologist and co-leader of the Markey Cancer Center Molecular Tumor Board discusses the findings in Sunday's Herald-Leader.
↧